New Co-STAR Receptor Shows Promise Treating Cancers in Laboratory Study | Naviance

Un nuevo receptor Co-STAR se muestra prometedor en el tratamiento del cáncer en un estudio de laboratorio

New Co-STAR Receptor Shows Promise Treating Cancers in Laboratory Study

Utilizando técnicas de ingeniería genética, los investigadores del Centro Oncológico Johns Hopkins Kimmel y su Centro Ludwig, el Laboratorio de Lustgarten y Bloomberg~Instituto Kimmel de Inmunoterapia contra el Cáncer Han diseñado un nuevo tipo de célula para reconocer y combatir el cáncer.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment